BioHarvest Sciences Inc. (BHST)

Market Cap	100.19M +0.7%
Revenue (ttm)	34.51M +37.0%
Net Income	-11.14M
EPS	-0.60
Shares Out	22.67M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,013
Open	4.330
Previous Close	4.350
Day's Range	4.310 - 4.610
52-Week Range	4.100 - 12.800
Beta	1.40
Analysts	Strong Buy
Price Target	10.00 (+126.24%)
Earnings Date	May 14, 2026

About BHST

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2007
• Employees: 89
• Stock Exchange: NASDAQ
• Ticker Symbol: BHST
• Website: https://www.bioharvest.com

Financial Performance

In 2025, BioHarvest Sciences's revenue was $34.51 million, an increase of 37.00% compared to the previous year's $25.19 million. Losses were -$11.14 million, -13.77% less than in 2024.

Analyst Summary

According to one analyst, the rating for BHST stock is "Strong Buy" and the 12-month stock price target is $10.0.

Price Target

$10.0

(126.24% upside)

Analyst Consensus: Strong Buy